A MURINE GASTRIC CANCER YTN16 MODEL FOR THE RATIONAL DESIGN OF COMBINATION IMMUNOTHERAPY

被引：0
|
作者：
Nagaoka, Koji [1 ]
Sun, Changbo [1 ]
Kobayashi, Yukari [1 ]
Kakimi, Kazuhiro [1 ]
机构：
[1] Univ Tokyo Hosp, Tokyo, Japan
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.913
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
913
引用
收藏
页码：A959 / A959
页数：1
相关论文
共 50 条
  • [21] A novel murine in vivo model to evaluate the potential of immunotherapy of gastric carcinoma
    van den Engel, N
    Noeckel, J
    Winter, H
    Hatz, R
    Zimmermann, W
    Kammerer, R
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S34 - S34
  • [22] Identification of biomarker candidates to predict response in the combination immunotherapy for gastric cancer
    Ohta, Shigeki
    Izawa, Naoki
    Misawa, Aya
    Katoh, Yuki
    Kubo, Akiko
    Kadowaki, Shigenori
    Minashi, Keiko
    Nishina, Tomohiro
    Eguchi, Takako Nakajima
    Kawakami, Yutaka
    CANCER SCIENCE, 2022, 113 : 396 - 396
  • [23] Combination immunotherapy with PD-L1 blockade and Poly I:C in a murine breast cancer model
    Soliman, Hatem
    Nelson, Ashley R.
    CANCER RESEARCH, 2014, 74 (19)
  • [24] Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model
    Garg, Himani
    Hada, Rohit Singh
    Gupta, Jagdish C.
    Talwar, G. P.
    Dubey, Shweta
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2018, 9 (08): : 188 - 199
  • [25] Rational design of recombinant modified vaccinia virus Ankara for cancer immunotherapy
    Yang, N.
    Wang, Y.
    Shuman, S.
    Merghoub, T.
    Wolchok, J. D.
    Deng, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S144 - S144
  • [26] A Pathway-based Design of Rational Combination Therapies for Cancer
    Vera-Licona, P.
    Zinovyev, A.
    Bonnet, E.
    Kuperstein, I.
    Kel, O.
    Kel, A.
    Dubois, T.
    Tucker, G.
    Barillot, E.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S154 - S154
  • [27] Rational design of small molecule RHOA inhibitors for gastric cancer
    Jin-Hee Kim
    Sungjin Park
    Seung Mook Lim
    Hyo Jin Eom
    Curt Balch
    Jinhyuk Lee
    Gi Jin Kim
    Jin-Hyun Jeong
    Seungyoon Nam
    Yon Hui Kim
    The Pharmacogenomics Journal, 2020, 20 : 601 - 612
  • [28] Rational design of small molecule RHOA inhibitors for gastric cancer
    Kim, Jin-Hee
    Park, Sungjin
    Lim, Seung Mook
    Eom, Hyo Jin
    Balch, Curt
    Lee, Jinhyuk
    Kim, Gi Jin
    Jeong, Jin-Hyun
    Nam, Seungyoon
    Kim, Yon Hui
    PHARMACOGENOMICS JOURNAL, 2020, 20 (04): : 601 - 612
  • [29] Chemo-immunotherapy of ovarian cancer in a murine tumour model
    Klimp, AH
    De Vries, EGE
    Scherphof, GL
    Daemen, T
    ANTICANCER RESEARCH, 2000, 20 (04) : 2585 - 2592
  • [30] Combining activatable nanodelivery with immunotherapy in a murine breast cancer model
    Kheirolomoom, Azadeh
    Silvestrini, Matthew T.
    Ingham, Elizabeth S.
    Mahakian, Lisa M.
    Tam, Sarah M.
    Tumbale, Spencer K.
    Foiret, Josquin
    Hubbard, Neil E.
    Borowsky, Alexander D.
    Ferrara, Katherine W.
    JOURNAL OF CONTROLLED RELEASE, 2019, 303 : 42 - 54
12345